{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T02:53:47Z","timestamp":1764212027914},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1097\/md.0000000000007650","type":"journal-article","created":{"date-parts":[[2017,7,25]],"date-time":"2017-07-25T19:38:09Z","timestamp":1501011489000},"page":"e7650","source":"Crossref","is-referenced-by-count":4,"title":["TACE plus percutaneous chemotherapy-lipiodol treatment of unresectable pedunculated hepatocellular carcinoma"],"prefix":"10.1097","volume":"96","author":[{"given":"Dexiao","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingle","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-61-20210309","first-page":"114","article-title":"Un cas de cancer primitif du foie avec pericholecystite calculeuse, perforation intestinale: hemostase hepatique","volume":"17","author":"Roux","year":"1897","journal-title":"Rev Med Suisse Romande"},{"key":"R2-61-20210309","first-page":"506","article-title":"Uber das primare Carcinom der Leber","volume":"30","author":"Eggel","year":"1901","journal-title":"Beitr Pathol Anat Allg Pathol"},{"key":"R3-61-20210309","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/1097-0142(19830215)51:4<746::AID-CNCR2820510433>3.0.CO;2-#","article-title":"Pedunculated hepatocellular carcinoma. Report of three cases and review of literature","volume":"51","author":"Horie","year":"1983","journal-title":"Cancer"},{"key":"R4-61-20210309","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000011996","article-title":"Prognosis for pedunculated hepatocellular carcinoma","volume":"57","author":"Horie","year":"1999","journal-title":"Oncology"},{"key":"R5-61-20210309","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archsurg.1988.01400300118021","article-title":"Surgical therapy in two patients with pedunculated hepatocellular carcinoma","volume":"123","author":"Moritz","year":"1988","journal-title":"Arch Surg"},{"key":"R6-61-20210309","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00268-002-6401-x","article-title":"Pedunculated hepatocellular carcinoma: clinicopathologic study of 18 surgically resected cases","volume":"26","author":"Yeh","year":"2002","journal-title":"World J Surg"},{"key":"R7-61-20210309","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1987.tb02645.x","article-title":"Pedunculated hepatocellular carcinoma. Is it an entity?","volume":"11","author":"Anthony","year":"1987","journal-title":"Histopathology"},{"key":"R8-61-20210309","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1634\/theoncologist.2010-S4-42","article-title":"Treatment of intermediate\/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?","volume":"15","author":"Lencioni","year":"2010","journal-title":"Oncologist"},{"key":"R9-61-20210309","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"R10-61-20210309","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"R11-61-20210309","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1365-2036.2006.02932.x","article-title":"Systematic review: evidence-based management of hepatocellular carcinoma\u2014an updated analysis of randomized controlled trials","volume":"23","author":"Lopez","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R12-61-20210309","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.3748\/wjg.v11.i39.6104","article-title":"Combined TACE and PET for palliative treatment of unresectable hepatocellular carcinoma","volume":"11","author":"Becker","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R13-61-20210309","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"R14-61-20210309","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jvir.2008.10.019","article-title":"Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5\u200acm","volume":"20","author":"Takaki","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"R15-61-20210309","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.3748\/wjg.v19.i26.4192","article-title":"Transcatheter arterial chemoembolization followed by immediate radiofrequency ablation for large solitary hepatocellular carcinomas","volume":"19","author":"Wang","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R16-61-20210309","first-page":"2526","article-title":"Effect of percutaneous intratumoral injection of lipiodol emulsion of chemotherapie agents on implanted VX2 tumor in rabbits","volume":"30","author":"Song","year":"2010","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"R17-61-20210309","first-page":"992","article-title":"Percutaneous intratumoral injection of lipiodol and chemotherapeutic agents emulsion for primary liver cancer","volume":"24","author":"Chen","year":"2009","journal-title":"Chin J Gen Surg"},{"key":"R18-61-20210309","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3348\/kjr.2013.14.5.823","article-title":"Image-guided percutaneous lipiodol-pingyangmycin suspension injection therapy for sacral chordoma","volume":"14","author":"Huang","year":"2013","journal-title":"Korean J Radiol"},{"key":"R19-61-20210309","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/bjc.1993.20","article-title":"Pedunculated hepatocellular carcinoma and surgical treatment","volume":"67","author":"Nishizaki","year":"1993","journal-title":"Br J Cancer"},{"key":"R20-61-20210309","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1148\/radiol.10101058","article-title":"Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival","volume":"258","author":"Chung","year":"2011","journal-title":"Radiology"},{"key":"R21-61-20210309","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/107327480801500110","article-title":"Transcatheter arterial chemoembolization and percutaneous ethanol injection for Hepatocellular carcinoma: a retrospective review of the Veterans Affairs Caribbean Healthcare System","volume":"15","author":"Narvaez-Lugo","year":"2008","journal-title":"Cancer Control"},{"key":"R22-61-20210309","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jvir.2010.04.015","article-title":"Chemoembolization for the treatment of large hepatocellular carcinoma","volume":"21","author":"Miyayama","year":"2010","journal-title":"J Vasc Interv Radiol"},{"key":"R23-61-20210309","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1186\/1471-230X-9-31","article-title":"Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma","volume":"9","author":"Bouza","year":"2009","journal-title":"BMC Gastroenterol"},{"key":"R24-61-20210309","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3748\/wjg.14.1997","article-title":"Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma","volume":"14","author":"Taniguchi","year":"2008","journal-title":"World J Gastroenterol"},{"key":"R25-61-20210309","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.3748\/wjg.15.2651","article-title":"Major complications after radiofrequency ablation for liver tumors: analysis of 255 patients","volume":"15","author":"Kong","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R26-61-20210309","first-page":"6","article-title":"Improvement of differential toxicity between tumor and normal tissues using intratumoral injection with or without a slow-drug-release matrix system.","volume":"133-","author":"Begg","year":"1988","journal-title":"NCI Monogr"},{"key":"R27-61-20210309","first-page":"1121","article-title":"Direct percutaneous intratumoral bleomycin injection for palliative treatment of impending quadriplegia","volume":"25","author":"Duncan","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"key":"R28-61-20210309","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2214\/AJR.09.3964","article-title":"Semiautomated segmentation for volumetric analysis of intratumoral ethiodol uptake and subsequent tumor necrosis after chemoembolization","volume":"195","author":"Monsky","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"R29-61-20210309","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2214\/ajr.175.3.1750699","article-title":"Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma","volume":"175","author":"Takayasu","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"R30-61-20210309","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.7150\/jca.15405","article-title":"The degree of lipiodol accumulation can be an indicator of successful treatment for unresectable hepatocellular carcinoma (HCC) patients\u2014in the case of transcatheter arterial chemoembolization (TACE) and external beam radiotherapy (EBRT)","volume":"7","author":"Yang","year":"2016","journal-title":"J Cancer"},{"key":"R31-61-20210309","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1365-2036.2012.05089.x","article-title":"Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma","volume":"35","author":"Kim","year":"2012","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000007650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:56:03Z","timestamp":1620960963000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201707280-00061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":31,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000007650","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}